Hypoxia re-programs 2′-O-Me modifications on ribosomal RNA

by Brandon J. Metge, Sarah C. Kammerud, Hawley C. Pruitt, Lalita A. Shevde, Rajeev S. Samant
Published 2021-01-01

Merlin deficiency alters the redox management program in breast cancer

by Mateus Mota, Brandon J. Metge, Dominique C. Hinshaw, Heba A. Alsheikh, Dongquan Chen, Rajeev S. Samant, Lalita A. Shevde
Published 2021-04-01

Inhibition of Hedgehog signaling reprograms the dysfunctional immune microenvironment in breast cancer

by Ann Hanna, Brandon J. Metge, Sarah K. Bailey, Dongquan Chen, Darshan S. Chandrashekar, Sooryanarayana Varambally, Rajeev S. Samant, Lalita A. Shevde
Published 2019-03-01

Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors

by Heba Allah M. Alsheikh, Brandon J. Metge, Hawley C. Pruitt, Sarah C. Kammerud, Dongquan Chen, Shi Wei, Lalita A. Shevde, Rajeev S. Samant
Published 2021-06-01

Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer

by Shannon E. Weeks, Sarah C. Kammerud, Brandon J. Metge, Heba A. AlSheikh, David A. Schneider, Dongquan Chen, Shi Wei, James A. Mobley, Akinyemi I. Ojesina, Lalita A. Shevde, Rajeev S. Samant
Published 2021-03-01